Treatment of castration‐resistant prostate cancer and bone metastases with radium‐223 dichloride-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of castration‐resistant prostate cancer and bone metastases with radium‐223 dichloride

Published:2014-10-14 Issue:1 Volume:9 Page:3-13
ISSN:1749-7701
Container-title:International Journal of Urological Nursing
language:en
Short-container-title:Int J Urol Nurs

Author:

Lien Lise Marie E¹,Tvedt Birger²,Heinrich Daniel³

Affiliation:

1. Department of Oncology and Medical Physics Haukeland University Hospital Helse‐Bergen Bergen Norway

2. Department of Radiology Center for Nuclear Medicine/PET Haukeland University Hospital Helse‐Bergen Bergen Norway

3. Department of Oncology Akershus University Hospital Lørenskog Norway

Publisher

Wiley

Subject

Nursing (miscellaneous),Urology,Nephrology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijun.12059

Reference42 articles.

1. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

3. Meeting the Nursing Challenges Intreating Children with 131 I-MIBG

4. High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities?

5. Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-body MRI: detecting bone metastases from prostate cancer;Japanese Journal of Radiology;2021-10-25

2. A cell-based dosimetry model for radium-223 dichloride therapy using bone micro-CT images and GATE simulations;Physics in Medicine & Biology;2020-02-12

3. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why;Tumori Journal;2019-05-16

4. Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer;American Journal of Clinical Oncology;2019-04

5. Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer;Health Economics Review;2018-10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3